These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12444308)

  • 1. Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad.
    Frayn KN
    Med Princ Pract; 2002; 11 Suppl 2():31-40. PubMed ID: 12444308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond fasting plasma glucose: the association between coronary heart disease risk and postprandial glucose, postprandial insulin and insulin resistance in healthy, nondiabetic adults.
    Bhat SL; Abbasi FA; Blasey C; Reaven GM; Kim SH
    Metabolism; 2013 Sep; 62(9):1223-6. PubMed ID: 23809477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Westernisation, insulin resistance and diabetes in Australian aborigines.
    O'Dea K
    Med J Aust; 1991 Aug; 155(4):258-64. PubMed ID: 1875844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism.
    Lopez-Miranda J; Williams C; Lairon D
    Br J Nutr; 2007 Sep; 98(3):458-73. PubMed ID: 17705891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease.
    Lamarche B
    Coron Artery Dis; 1998; 9(8):473-81. PubMed ID: 9847978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and coronary heart disease in nondiabetic individuals.
    Reaven G
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1754-9. PubMed ID: 22815340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of postprandial hyperlipidaemia--remnants and coronary artery disease.
    Karpe F
    Diabet Med; 1997 Aug; 14 Suppl 3():S60-6. PubMed ID: 9272616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial lipid handling.
    Griffin BA; Fielding BA
    Curr Opin Clin Nutr Metab Care; 2001 Mar; 4(2):93-8. PubMed ID: 11224651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of large-volume liposuction on metabolic risk factors for coronary heart disease.
    Mohammed BS; Cohen S; Reeds D; Young VL; Klein S
    Obesity (Silver Spring); 2008 Dec; 16(12):2648-51. PubMed ID: 18820648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal.
    Elliott TG; Viberti G
    Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):1079-103. PubMed ID: 8304914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between lipid abnormalities and insulin resistance in Japanese school children.
    Asato Y; Katsuren K; Ohshiro T; Kikawa K; Shimabukuro T; Ohta T
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2781-6. PubMed ID: 16990559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
    McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G
    Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
    Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
    Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and free fatty acids: double trouble.
    Castro Cabezas M; Halkes CJ; Erkelens DW
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):134-42. PubMed ID: 11434190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential benefits of weight loss in coronary heart disease.
    Ades PA; Savage PD
    Prog Cardiovasc Dis; 2014; 56(4):448-56. PubMed ID: 24438737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-pharmacological therapy of metabolic syndrome].
    Wirth A
    Herz; 1995 Feb; 20(1):56-69. PubMed ID: 7713478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
    Borgia MC; Medici F
    Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.